16 employees
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
2022
$20M
from 5 investors over 5 rounds
ArrePath raised $20M on March 3, 2022
Investors: Innospark Ventures, Nor'easter Ventures, Viva BioInnovator, Insight Partners and PTX Capital